Literature DB >> 33717146

Recurrent Sepsis Exacerbates CD4+ T Cell Exhaustion and Decreases Antiviral Immune Responses.

Wanxue He1, Kun Xiao1, Jiaruo Xu1, Wei Guan1, Sheling Xie1, Kaifei Wang1, Peng Yan1, Min Fang2, Lixin Xie1.   

Abstract

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to an infection. It is a disease with a high incidence, mortality, and recurrence rate and frequently results in its survivors requiring readmission into hospitals. The readmission is mainly due to recurrent sepsis. Patients with recurrent sepsis are more susceptible to secondary infections partly due to immune dysfunction, leading to a higher mortality in the long term. However, there remains a gap in the understanding of immunological characteristics and underlying mechanisms of recurrent sepsis. In this study, we used mouse models of acute and recurrent sepsis to investigate their different immunological characteristics. And then we subjected the two mouse models to a secondary influenza A virus (H1N1) infection and characterized the different immune responses. Here, we demonstrated that CD4+ T cells present an exacerbated exhaustion phenotype in response to recurrent sepsis as illustrated by the decreased frequency of CD4+ T cells, reduced co-stimulatory CD28 and increased inhibitory PD-1 and Tim-3 expression on CD4+ T cells, increased frequency of regulatory T cells, and reduced MHC-II expression on antigen-presenting cells. Moreover, we showed that antiviral immune responses decrease in the recurrent sepsis mouse model subjected to a secondary infection as illustrated by the reduced pathogen clearance and inflammatory response. This may be a consequence of the exacerbated CD4+ T cell exhaustion. In summary, recurrent sepsis exacerbates CD4+ T cell exhaustion and decreases antiviral immune responses, contributing to significant morbidity, increased late mortality, and increased health care burden in recurrent sepsis patients.
Copyright © 2021 He, Xiao, Xu, Guan, Xie, Wang, Yan, Fang and Xie.

Entities:  

Keywords:  T cell exhaustion; adaptive immune system; immune dysfunction; recurrent sepsis; secondary virus infection; sepsis

Mesh:

Year:  2021        PMID: 33717146      PMCID: PMC7946831          DOI: 10.3389/fimmu.2021.627435

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  61 in total

1.  Increased susceptibility to Candida infection following cecal ligation and puncture.

Authors:  Christopher G Davis; Kathy Chang; Dale Osborne; Andrew H Walton; W Michael Dunne; Jared T Muenzer
Journal:  Biochem Biophys Res Commun       Date:  2011-09-12       Impact factor: 3.575

2.  Evaluation of humoral immune response to nosocomial pathogen and functional status in elderly patients with sepsis.

Authors:  Su Jin Jeong; Sang Sun Yoon; Sang Hoon Han; Dong Eun Yong; Chang Oh Kim; June Myung Kim
Journal:  Arch Gerontol Geriatr       Date:  2013-08-30       Impact factor: 3.250

3.  Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis.

Authors:  Sachin Yende; Gina D'Angelo; John A Kellum; Lisa Weissfeld; Jonathan Fine; Robert D Welch; Lan Kong; Melinda Carter; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2008-03-27       Impact factor: 21.405

Review 4.  Origins of CD4(+) effector and central memory T cells.

Authors:  Marion Pepper; Marc K Jenkins
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

5.  Preoperative CD4 count or CD4/CD8 ratio as a useful indicator for postoperative sepsis in HIV-infected patients undergoing abdominal operations.

Authors:  Xian-Jun Xia; Bao-Chi Liu; Jin-Song Su; Hui Pei; Hui Chen; Lei Li; Yong-Fu Liu
Journal:  J Surg Res       Date:  2011-10-25       Impact factor: 2.192

6.  Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis.

Authors:  Guillaume Monneret; Anne-Lise Debard; Fabienne Venet; Julien Bohe; Olivier Hequet; Jacques Bienvenu; Alain Lepape
Journal:  Crit Care Med       Date:  2003-07       Impact factor: 7.598

7.  Risk of Recurrence After Surviving Severe Sepsis: A Matched Cohort Study.

Authors:  Hsiu-Nien Shen; Chin-Li Lu; Hsi-Hsing Yang
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

8.  Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.

Authors:  S T O'Sullivan; J A Lederer; A F Horgan; D H Chin; J A Mannick; M L Rodrick
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

9.  Subsequent infections in survivors of sepsis: epidemiology and outcomes.

Authors:  Tisha Wang; Ariss Derhovanessian; Sharon De Cruz; John A Belperio; Jane C Deng; Guy Soo Hoo
Journal:  J Intensive Care Med       Date:  2012-12-26       Impact factor: 3.510

10.  Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis.

Authors:  Caiyi C Li; Ivana Munitic; Paul R Mittelstadt; Ehydel Castro; Jonathan D Ashwell
Journal:  PLoS Biol       Date:  2015-10-06       Impact factor: 8.029

View more
  3 in total

1.  β-glucan-coupled superparamagnetic iron oxide nanoparticles induce trained immunity to protect mice against sepsis.

Authors:  Yuchen Pan; Jingman Li; Xiaoyu Xia; Jiali Wang; Qi Jiang; Jingjing Yang; Huan Dou; Huaping Liang; Kuanyu Li; Yayi Hou
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 2.  Regulatory T Cells: Angels or Demons in the Pathophysiology of Sepsis?

Authors:  Yu-Lei Gao; Ying Yao; Xiang Zhang; Fang Chen; Xiang-Long Meng; Xin-Sen Chen; Chao-Lan Wang; Yan-Cun Liu; Xin Tian; Song-Tao Shou; Yan-Fen Chai
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

3.  ELEVATED PD-1/CD28 RATIO RATHER THAN PD-1 EXPRESSION IN CD8+ T CELLS PREDICTS NOSOCOMIAL INFECTION IN SEPSIS PATIENTS: A PROSPECTIVE, OBSERVATIONAL COHORT STUDY.

Authors:  Wenhong Zhong; Jing Li; Dongxin Li; Xusheng Li; Mengting Liu; Tiancao Zhang; Junhong Huang; Guoge Huang; Hongke Zeng; Maohua Zhou; Wenqiang Jiang
Journal:  Shock       Date:  2022-07-30       Impact factor: 3.533

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.